Genzyme Corporation (GENZ) Convenes 1st International Gaucher Conference on Bone Disease
7/1/2013 7:06:34 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), today announced that the first international meeting focused on bone disease in patients with Gaucher disease will take place July 5 and 6 in Rio de Janeiro, Brazil. This meeting will bring together over 100 physicians and researchers from around the world, with the goal of improving clinical care and shaping the future direction of research specific to bone disease.
Help employers find you! Check out all the jobs and post your resume.
comments powered by